Acromegaly
Nestoras Mathioudakis, M.D.; Douglas Ball, M.D.
DEFINITION
- A clinical syndrome resulting from excessive secretion of growth hormone (GH).
- GH excess prior to closure of the epiphyseal plates results in gigantism; after epiphyseal plate closure, the result is acromegaly.
- Somatic and metabolic effects of chronic GH hypersecretion are predominantly mediated by high levels of insulin-like growth factor-1 (IGF-1).
- Acromegaly is an uncommon secondary cause of diabetes.
- Excess GH: 1) stimulates gluconeogenesis and lipolysis, causing hyperglycemia and elevated free fatty acid levels; 2) leads to both hepatic and peripheral insulin resistance, with compensatory hyperinsulinemia. Conversely, IGF-1 increases insulin sensitivity. However, in acromegaly, increased IGF-1 levels are unable to overcome the insulin-resistant state caused by GH excess.
Acromegaly was found in Johns Hopkins Diabetes Guide.
If you are a registered user, please log in below.
If not, learn more about gaining full access.
- Login
- Try
- Johns Hopkins Guides include up-to-date, authoritative content to help you treat patients and raise the standard of care.
Try these free topics now!
Johns Hopkins ABX Guide
Johns Hopkins Diabetes Guide
Johns Hopkins HIV Guide